Article | August 31, 2022

Current Trends In Gene Therapy According To Citeline Data (Jan 2017–Aug 2022)

By Andy Kinley


An analysis of gene therapy clinical trial data collected over the past 5+ years

The success of gene therapies to date continues to spark an exciting second wave that is laying the foundation for next-generation technologies across several therapeutic areas—oncology, cardiovascular, muscular disorders, neurological conditions, and others.

To confirm our suspicions of an upward tick in the number of gene therapy programs initiated year over year, we turned to Citeline for a glimpse at the real figures.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene